Latanoprost plus brimonidine controls IOP

Article

Austin, TX-Patients who need more than one ocular hypotensive agent to achieve low IOP may benefit more from a regimen of latanoprost (Xalatan, Pharmacia) and adjunctive brimonidine (Alphagan, Allergan) than from dual therapy with latanoprost and timolol, according to a recent study.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.